Elon Musk's Neuralink wants to start testing a brain-computer interface on humans next year. "But some worry that Neuralink's invasive method is risky." You don't say.
UBS: ". We find the timing of the tweet (& the method itself) interesting given less than a week ago the company said it would be profitable with positive cash flow in Q3/Q4. In our view, this may be another way for Musk to change the conversation around the company .." $TSLA